HHS Task Force Mammogram Recs Slammed


"The (task force) recommends against routine screening mammography in women aged 40 to 49 years." U.S. Preventative Services Task Force, Nov. 17, 2009

"My message to women is simple. Mammograms have always been an important life-saving tool in the fight against breast cancer and they still are today. Keep doing what you have been doing for years - talk to your doctor about your individual history, ask questions, and make the decision that is right for you." Kathleen Sebelius, Health and Human Services Secretary, Nov. 18.

Talk about a short news cycle. A Department of Health and Human Services (HHS) appointed "best practices" task force dismissed the value of "routine" mammograms as a cancer prevention technique for women 40 to 49 years on Tuesday, November 17.

More after the jump.

A day later, Wednesday, Nov. 18, HHS Secretary Kathleen Sebelius issued a statement dismissing the committee recommendations.

'The U.S. Preventive Task Force is an outside independent panel of doctors and scientists who make recommendations.

"They do not set federal policy and they don't determine what services are covered by the federal government." Kathleen Sebelius, Nov. 18.

The committee is made up of independent practitioners but operates under the sponsorship of the Agency for Healthcare Research and Quality, HHS. The agency states that their task force "recommendations have formed the basis of the clinical standards for many professional societies, health organizations, and medical quality review groups."

Sebelius didn't care. Amidst Republican outcries that this was the way Democratic sponsored health reform would operate, she issued her terse statement dismissing the dismissal of mammography for women 40 to 49.

The DC flap started when had task force member Dr. Diane Pettiti, MD on her show yesterday, Nov. 18. She asked the doctor for the name of one cancer specialist on the task force. Petitti was unable to answer (video 1:53). The doctor also told Rehm that "Cost effectiveness was not a part of the discussion. Cost was not uttered in the room."

Dr. Rebecca Zurrbier, MD, Chief of Breast Imaging at Sibley Memorial Hospital in Washington, DC was listening to the Rehm show and became incensed. She pointed out that no one on the committee had either a clinical specialty or indicated any direct experience in treating cancer in a WUSA, Channel 9 special news feature (video). Zurrbier's WUSA critique was a devastating counterpoint to Rehm's skilful questioning on her radio show earlier in the day.

The HHS sponsored task force had 16 members. These members issued a statement on cancer treatment. There is not one oncologist on the panel nor is there a radiologist. The specialties of task force physicians consist of: Family Medcine (4 members); Pediatrics (2); Obstetrics and Gynecology (2); Internal Medicine (2); Geriatrics (1); Epidemiology (1); Primary Care (1). The non MD's had these specialties: Nurse Practitioner - Psychiatry (1); Nurse Practitioner - Family Medicine (1); and, PhD researcher (1).

If you were seeking treatment for cancer or consultation on current treatment, would you consult anyone with the specialties listed? Not if you're concerned about your health. Cancer is not what these doctors treat. Dr. Zurrbier's point was so obvious, she seemed amazed that this kind of finding could even occur. So should we.

WUSA's did an on-the-spot review of task force member affiliations. They came up with three members tied to HMO's or health insurance companies. Dr. George Isham, MD is the Chief Health Officer for a major health care provider, Health Partners. Dr. David Grossman, MD, is an investigator a research division of the Group Health Cooperative health care network in the Seattle area. Dr. J. Sanford Schwartz, MD, is the past executive director of the Leonard Davis Institute of Health Economics at the University of Pennsylvania. He's also on the Blue Shield Medical Advisory Panel.

There are three other affiliations that deserve note.

Task force Chairman, Bruce Nedrow Calonge, MD, is a Colorado physician who is the Chairman of the Colorado Foundation for Medical Care, a major advisor on "quality improvement" in care for the state and other health care organizations. Dr. Pettiti, who said the recommendations would have no influence on insurance coverage, is a health policy and medical advisor for Kaiser Permanente of Southern California. Joy Melnikow, MD is the associate medical advisers for Healthwise, a medical knowledgebase company serving health providers, insurance companies, and government entities. The firm also provides software for patient information.

Thanks to the incisive questioning of NPR syndicated radio host Diane Rehm and the quick and clear response of cancer specialist, Dr. Zurrbier on WUSA, the issue hit the public airwaves and was quickly resolved with the rapid response of HHS Secretary Sebelius.

Now it's time to find out how this HHS research organization could impanel a group of experts to recommend cancer treatment protocols when none of the physicians on the panel were oncologists and none had any identified clinical experience treating cancer. It's also a good time for those on the task force to examine why they chose to issue this guideline without cancer researchers and clinicians on the committee?

Why were the deficiencies in this process, so obvious to us, too difficult for the HHS administrators to grasp?

END

This article may be reproduced in whole or in part with attribution of authorship and a link to this article.


Michael Collins November 19, 2009 - 7:53am
( categories: Health Issues )

who appointed this new group?

In Reversal, Panel Urges Mammograms at 50, Not 40

Gina Kolata | Nov 17

NYT - Most women should start regular breast cancer screening at age 50, not 40, according to new guidelines released Monday by an influential group that provides guidance to doctors, insurance companies and policy makers.

The new recommendations, which do not apply to a small group of women with unusual risk factors for breast cancer, reverse longstanding guidelines and are aimed at reducing harm from overtreatment, the group says. It also says women age 50 to 74 should have mammograms less frequently — every two years, rather than every year. And it said doctors should stop teaching women to examine their breasts on a regular basis.

Just seven years ago, the same group, the United States Preventive Services Task Force, with different members, recommended that women have mammograms every one to two years starting at age 40. It found too little evidence to take a stand on breast self-examinations.

The task force is an independent panel of experts in prevention and primary care appointed by the federal Department of Health and Human Services.

Its new guidelines, which are different from those of some professional and advocacy organizations, are published online in The Annals of Internal Medicine They are likely to touch off yet another round of controversy over the benefits of screening for breast cancer.

more

Tina November 19, 2009 - 9:06am

I think they sandbagged Obama and Sebelius. Her staff screwed up or got screwed. The three WUSA found and the additional members that I mentioned for dodgy interests should all be fired, tomorrow would be fine. This is not an expert panel. Each medical discipline has it's own panels for best practices. In fact, the disciplines all have subgorups that generally have real experts. It's an honor to be selected. These folks really work. But this task force looks like it's guilty of practicing outside of its area of competence. Really, pediatricians, OBGYNS, family medicine folks talking about oncology. Big difference between clinical practices and some meta analysis by lord knows who.

Michael Collins November 19, 2009 - 9:16am

The panel cooncluded that early mamograms "lead to false alarms and unneeded biopsies, without substantially improving odds of survival for women under 50." Would someone like to challenge that conclusion? So far, I haven't seen it refuted. You need to be an oncologist to treat cancer in an individual, but you certainly don't need to be one to do a competent job statistically analyzing outcomes of treatment.

It might be that their conclusion was wrong, and it might be that they were outside of their area of expertise, but the two aren't necessarily causally related. Simply yelling that they weren't oncologist or that they were insurance stoogies without addressing their CONCLUSION DIRECTLY is the same intellectual laziness that gave us global warming deniers. It's responding with emmotion and attacking credibility without addressing the issue.

BuddhaSixFour November 19, 2009 - 9:33am

I thought I was ridiculing the task force.

Your points are logically correct, on a technical level. However, when you change the consensus on treatment or challenge that consensus, you don't do it with people sans expertise. It doesn't work that way in medicine or any other discipline. What if a panel of air traffic controllers issued a best practices document for the railroad system in the USA? Technically, they might be right but there would be protest because of a flawed process. The same applies in medicine and this instance.

There are six members of a 11-12 member panel who are either with insurance companies or involved in squeezing the last dime out of the health insurance premium. That's a function of the system but people who perform that function are inherently biased in making clinical recommendations.

The decision is already being challenged, as the DC doctor did and the various health organizations. But I'm comfortable in saying that this process was designed to fail, is probably a shot at Obama or Sebelius due to the out of bounds conclusions.

Michael Collins November 19, 2009 - 9:55am

There was much discussion about the recommendation to start screening at 40 being a give away to the Health Sickness Industry by Bu$h appointees, and doubt about it's effectiveness because of breast density of 40 year women.

It cannot be both ways.

Snark: Is the breast density test a hands-on test?

Synoia November 19, 2009 - 11:59am

then I think I've found my new career... :P

Bolo November 19, 2009 - 2:59pm

If you're a railroad expert, you may very well be led to find that best practices require lots more rail equipment, facilities, and jobs. If only tool is a hammer, and all that. The frequency of C-sections (more convenient and lucrative than the alternative) in the U.S. appears to be driven by obstetricians, so I'd be wary of best practices panels composed only of obstetricians saying we ought to continue the high incidence.

Seems to me another indication that medical services should not be a for-profit enterprise.

nihil obstet November 19, 2009 - 11:36am

You can't have all insiders or all strangers on any best practices committee. What you need are devoted practitioners and researchers and a chairman with a reputation that she/he values. That wasn't the case here. I seem to recall something called "diagnostic related groups" way back that was a foot in the door for shrinking available care. It's a see-saw but we have a right to know the best science and practice and we've got more than enough talented and honest people who don't have ownership or business interests with health care conglomerates.

I'm an optimist on our future. There are many, many talented people devoted to their craft, science, art, etc. and there's plenty to do with even more people who will give an honest effort as part of a positive project. The worldwide Linux development project is proof that people will cooperate for the greater good. We ought to try that in other fields.

Michael Collins November 19, 2009 - 1:50pm

Erm as fascinating as the back-n-forth among appointees and the medical hoi polloi is, I would like to know more about whether this screening process imparts enough radiation to have a biological impact - particularly if it is an annual affair.

All EM radiation should be under a schema of regulatory clarity, much as all drugs/alcohol/tobacco should be under one schema. The people that are running this gig do NOT want some kind of regulation on hot things like cell phone towers. Radioactive medical imaging is usually said to be only 50x higher than background or whatever, but is this always true??

It is physically impossible for it to have a null effect - the most benign possible claim is that it's statistically insignificant. If in fact it's getting false positives then it could easily have a negative effect on public health as a whole, via misdirecting limited resources. (I am more concerned about non-medical radiation but it's the same basic pandora's box no one wants to open)

(ref this article http://www.naturalnews.com/027537_mammograms_cancer_industry.html )
--
Hongpong.com

HongPong November 19, 2009 - 1:02pm

but it depends on what type of radiation and for how long. UV radiation causes skin cancer, gamma and X-ray radiation can cause all sorts of other cancers. This part of the spectrum, with wavelengths shorter than visible light, is sometimes referred to as "ionizing," since the energy and scale of interaction with matter allow for ionization--in other words, this radiation can damage your DNA.

Visible light, infrared, and radio waves are less cancer-causing due to their longer wavelengths, lower energy, and (therefore) lower potential for interaction with biological systems.

Cellphones are in the radio portion of the spectrum, while x-rays are in... well, you can guess where. Mammograms require brief exposure to x-rays so therefore they do raise the probability of getting cancer. But if this additional risk is so small that it is statistically insignificant then you shouldn't have to worry about it. My understanding (not backed up by expertise here though) is that a weighting of the increased risk of cancer due to exposure to x-rays during a mammogram versus the benefit of being able to identify cancer early on comes down conclusively on the side of early detection.

Bolo November 19, 2009 - 3:16pm

November 20, 2009
Guidelines Push Back Age for Cervical Cancer Tests

By DENISE GRADY

New guidelines for cervical cancer screening say women should delay their first Pap test until age 21, and be screened less often than recommended in the past.

The advice, from the American College of Obstetricians and Gynecologists, is meant to decrease unnecessary testing and potentially harmful treatment, particularly in teenagers and young women. The group’s previous guidelines had recommended yearly testing for young women, starting within three years of their first sexual intercourse, but no later than age 21.

Arriving on the heels of hotly disputed guidelines calling for less use of mammography, the new recommendations might seem like part of a larger plan to slash cancer screening for women. But the timing was coincidental, said Dr. Cheryl B. Iglesia, the chairwoman of a panel in the obstetricians’ group that developed the Pap smear guidelines. The group updates its advice regularly based on new medical information, and Dr. Iglesia said the latest recommendations had been in the works for several years, “long before the Obama health plan came into existence.”

She called the timing crazy, uncanny and “an unfortunate perfect storm,” adding, “There’s no political agenda with regard to these recommendations.”

Dr. Iglesia said the argument for changing Pap screening was more compelling than that for cutting back on mammography — which the obstetricians’ group has staunchly opposed — because there is more potential for harm from the overuse of Pap tests. The reason is that young women are especially prone to develop abnormalities in the cervix that appear to be precancerous, but that will go away if left alone. But when Pap tests find the growths, doctors often remove them, with procedures that can injure the cervix and lead to problems later when a woman becomes pregnant, including premature birth and an increased risk of needing a Caesarean.

Still, the new recommendations for Pap tests are likely to feed a political debate in Washington over health care overhaul proposals. The mammogram advice led some Republicans to predict that such recommendations would lead to rationing.

Senator Tom Coburn, a Republican from Oklahoma who is also a physician, said in an interview that he would continue to offer Pap smears to sexually active young women. Democratic proposals to involve the government more deeply in the nation’s health care system, he said, would lead the new mammography, Pap smear and other guidelines to be adopted without regard to patient differences, hurting many people.

“These are going to be set in stone,” Mr. Coburn said.

Senator Arlen Specter, a Pennsylvania Democrat and longtime advocate for cancer screening, said in an interview: “And this Pap smear guideline is yet another cut back in screening? That is curious.” Mr. Specter, who was treated for Hodgkin’s lymphoma in 2005 and 2008, said Congress was committed to increasing cancer screenings, not limiting them.

Representative Rosa DeLauro, Democrat of Connecticut, said that the new guidelines would have no effect on federal policy and that “Republicans are using these new recommendations as a distraction.”

“Making such arguments, especially at this critical point in the debate, merely clouds the very simple issue that our health reform bill would increase access to care for millions of women across the country,” she said.

There are 11,270 new cases of cervical cancer and 4,070 deaths per year in the United States. One to 2 cases occur per 1,000,000 girls ages 15 to 19 — a low incidence that convinces many doctors that it is safe to wait until 21 to screen.

more

Tina November 20, 2009 - 2:31am

Comment viewing options

Select your preferred way to display the comments and click "Save settings" to activate your changes.